New Study Finds Long COVID and ME/CFS Muscle Changes Exceed Those Caused by Bed Rest
A study in Nature Communications reveals that skeletal muscle adaptations in patients with long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) differ significantly from those caused by 60 days of bed rest in healthy individuals. While bed rest leads to muscle atrophy without changing fiber types, patients exhibit more glycolytic fibers and specific type I atrophy. The findings suggest that physical inactivity alone cannot explain the reduced exercise capacity and muscle changes in these conditions.
Key points
- The study compared whole-body exercise responses and skeletal muscle adaptations in long COVID and ME/CFS patients against healthy controls who underwent 60 days of strict bed rest.
- Bed rest resulted in muscle atrophy but did not alter muscle fiber types, whereas both patient groups displayed a higher proportion of glycolytic fibers.
- ME/CFS patients specifically showed atrophy in type I muscle fibers, a pattern not observed in the bed rest group.
- Oxidative phosphorylation capacity was only associated with maximal oxygen uptake after bed rest, not in the patient groups, indicating distinct metabolic impairments.
- The research concludes that physical inactivity is insufficient to account for the lower exercise capacity and specific skeletal muscle adaptations seen in long COVID and ME/CFS patients.
Background
Previous coverage has highlighted the ongoing challenges of long COVID, including early trials showing that Paxlovid and metformin may reduce the risk of developing the condition. Additionally, historical cases like that of polio survivor Martha Lillard have drawn attention to the long-term physical impacts of chronic illnesses and potential links to post-polio syndrome and long COVID. This new study adds to the understanding of the physiological mechanisms underlying these chronic conditions, moving beyond simple inactivity models.
Why it matters
This research provides critical evidence that the muscle dysfunction in long COVID and ME/CFS is not merely a result of reduced activity. By identifying distinct metabolic and structural changes in skeletal muscle, the study helps clarify the pathophysiology of these conditions. This distinction is vital for developing targeted treatments and rehabilitation strategies that address the underlying biological causes rather than just the symptoms of inactivity.
What to watch
Researchers will likely focus on identifying the specific mechanisms driving the shift to glycolytic fibers and type I atrophy in these patient groups. Future studies may explore whether these muscle changes are reversible with specific interventions or if they represent a permanent alteration in muscle physiology. Clinical trials may also investigate treatments that target these metabolic deficits to improve exercise capacity in patients.
Want the full story? Read the original reporting
Read on Nature